Where Data Tells the Story
© Voronoi 2025. All rights reserved.
After losing its position to J.P. Morgan in June 2025, Eli Lilly regained its rank as the 10th most valuable U.S. company after its market cap jumped 7% to $935 billion on November 10–11.
The surge followed Leerink Partners’ upgrade to “Outperform” and a raised price target of $1,104 (from $886), alongside 18% monthly gains fueled by Q3 earnings of $17.6 billion, up 54% year-over-year.